---

---

tags : Growth    symbols : INCY   

save search

---

CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market to Showcase Significant Growth at a CAGR of 15% by 2032 | DelveInsight
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -1.14% | O: -0.17% H: 1.41% C: -0.22%
t-cell for therapy growth market

---

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 12.13% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -13.68% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -8.11% | O: 0.14% H: 0.35% C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -7.41% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -7.44% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -3.58% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 1.83% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -2.91% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -4.57% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.08 -0.99% -0.99% 470K |

Health Technology

| -25.59% | O: -1.15% H: 1.03% C: -1.5%
VRTX | News | $394.43 0.24% 0.24% 1.3M |

Health Technology

| -5.63% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -1.49% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K |

Health Technology

| -8.91% | O: -3.1% H: 1.2% C: -0.8%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -8.68% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -20.26% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 11.16% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $360.11 0.47% 0.47% 330K |

Health Technology

| -5.61% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -10.02% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

---

Relapsing/Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032, Estimates DelveInsight | Leading Companies - Bristol-Myers Squibb, Allogene Therapeutics, Genentech, Pfizer, Ionis Pharmaceuticals, AbbVie, Amgen
Published: 2024-01-25 (Crawled : 22:00) - prnewswire.com
ACLX | $51.67 -5.19% -5.48% 740K |

| -6.94% | O: 0.2% H: 5.99% C: 5.65%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.89% | O: 0.8% H: 0.0% C: 0.0%
MTEM | $1.455 -2.02% -2.06% 13K |

Health Technology

| -60.16% | O: -2.94% H: 3.03% C: 3.03%
IONS | $40.64 -0.42% -0.42% 850K |

Health Technology

| -20.88% | O: 0.43% H: 0.27% C: -0.6%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -13.3% | O: 0.66% H: 0.64% C: -1.11%
IMAB | $1.81 0.56% 0.55% 340K |

Health Technology

| -0.55% | O: 1.1% H: 0.27% C: -1.64%
companies growth market

---

CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-23 (Crawled : 22:00) - prnewswire.com
ACLX | $51.67 -5.19% -5.48% 740K |

| -1.53% | O: 1.59% H: 1.14% C: -1.42%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 19.23% | O: 0.61% H: 1.52% C: 0.03%
PSTX | $2.02 1.0% 0.99% 640K |

Health Technology

| -35.89% | O: 1.57% H: 4.94% C: 1.54%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -14.63% | O: 0.29% H: 0.15% C: -1.95%
BEAM | $23.9 -1.69% -1.72% 4.5M |

Health Technology

| 2.8% | O: 1.88% H: 0.88% C: -2.79%
t-cell therapy growth study market

---

Incyte Highlights Growth Opportunities and Provides Business Updates at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -19.06% | O: -0.55% H: 1.45% C: 1.42%
conference business growth

---

Vitiligo Market Growth to Undergo Significant Changes by 2032, Predicts DelveInsight | Key Companies in the Market - Clinuvel Pharmaceuticals Limited, Pfizer, Incyte Corporation, Amgen
Published: 2023-11-07 (Crawled : 22:00) - prnewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -3.47% | O: 0.24% H: 0.0% C: -1.44%
companies pharmaceuticals growth market

---

Leptomeningeal Metastases Treatment Market to Register Immense Growth by 2032, Predicts DelveInsight
Published: 2023-10-11 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -15.85% | O: -0.97% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -17.01% | O: 0.14% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -7.27% | O: -0.05% H: 0.0% C: -0.63%
treatment growth market

---

Graft Versus Host Disease Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Assesses DelveInsight | Key Companies - Glia, Incyte, Novartis, GlaxoSmithKline, Pfizer, BMS, Roche, AstraZeneca, Sanofi
Published: 2023-09-27 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -14.17% | O: -2.28% H: 0.0% C: -0.06%
MCRB | $0.5671 -2.93% -3.02% 3.7M |

Health Technology

| -75.73% | O: 0.42% H: 0.63% C: -0.42%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -15.64% | O: -1.61% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -10.64% | O: 0.03% H: 0.34% C: -0.88%
disease companies sanofi growth market

---

CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio
Published: 2023-09-25 (Crawled : 21:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -9.49% | O: -0.45% H: 0.0% C: 0.0%
MESO | $5.19 1.57% 1.54% 230K |

Health Technology

| -47.64% | O: -3.28% H: 5.93% C: 4.24%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -10.09% | O: -0.32% H: 1.81% C: 1.23%
companies t-cell therapy growth market

---

Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte
Published: 2023-09-18 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -15.73% | O: -0.62% H: 0.0% C: -1.16%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 31.42% | O: 0.06% H: 1.19% C: 0.58%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -16.17% | O: -0.09% H: 1.16% C: 1.16%
MRUS | $39.83 -1.58% -1.61% 800K |

Health Technology

| 64.99% | O: -0.16% H: 2.46% C: 0.56%
KURA | $17.55 -0.74% -0.74% 1.3M |

Health Technology

| 87.59% | O: -0.1% H: 2.4% C: 0.52%
IOVA | News M | $11.32 -3.41% -3.53% 5.3M |

Health Technology

| 98.99% | O: -0.51% H: 1.5% C: -7.97%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -11.24% | O: 0.03% H: 2.18% C: 1.8%
FUSN | $21.26 0.05% 0.05% 440K |

Health Technology

| 701.51% | O: 0.0% H: 0.41% C: -2.26%
CALT | $17.65 -2.4% 4K |

Health Technology

| 2.2% | O: -6.2% H: 4.2% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -20.97% | O: -0.01% H: 1.99% C: 1.28%
companies cell growth market

---

Asthma Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - GlaxoSmithKline, AstraZeneca, Sanofi, Roche, Amgen, Regeneron, Incyte, Areteia, Suzhou Connect, Cumberland, Pulmatrix
Published: 2023-09-14 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -14.44% | O: 1.53% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -16.57% | O: 0.82% H: 0.0% C: 0.0%
RAPT | $7.96 0.38% 0.38% 790K |

Health Technology

| -58.15% | O: 0.16% H: 1.61% C: 1.35%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -16.79% | O: -0.08% H: 0.76% C: -1.39%
companies growth market

---

Essential Thrombocythemia Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - Imago BioSciences, Incyte, Karyopharm, Novartis, PharmaEssentia, Celgene, Kartos, Sierra Oncology
Published: 2023-08-30 (Crawled : 21:00) - prnewswire.com
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -19.05% | O: -0.09% H: 0.29% C: -1.01%
companies growth market

---

Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight
Published: 2023-08-21 (Crawled : 21:00) - prnewswire.com
COYA | $7.87 -6.75% -7.24% 54K |

| 136.26% | O: 2.92% H: 4.26% C: -0.28%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 37.03% | O: 0.3% H: 1.19% C: 0.75%
URGN | $13.78 -3.37% -3.48% 390K |

Health Technology

| -29.55% | O: 0.0% H: 2.26% C: -0.34%
SEEL | $0.3502 3.61% 3.48% 290K |

Health Technology

| -99.1% | O: 0.0% H: 0.0% C: -9.02%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -15.3% | O: 0.57% H: 0.0% C: 0.0%
PRTA 4 | $21.17 2.92% 2.83% 510K |

Health Technology

| -63.27% | O: 0.03% H: 1.36% C: -0.07%
IONS | $40.64 -0.42% -0.42% 850K |

Health Technology

| 4.11% | O: -0.15% H: 1.02% C: 0.46%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -18.59% | O: -0.08% H: 1.11% C: -0.06%
DNLI | $15.98 -3.74% -3.88% 1.5M |

Health Technology

| -25.48% | O: -0.6% H: 1.75% C: 0.3%
BIVI | $0.4874 -0.21% -0.21% 490K |

Health Technology

| -86.12% | O: -0.85% H: 3.43% C: 1.71%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -26.38% | O: -0.38% H: 0.67% C: -0.41%
global medical growth market

---

Multiple Myeloma Market to Observe Impressive Growth at a CAGR of ~5% During the Study Period (2019-2032), Assesses DelveInsight
Published: 2023-08-14 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -12.75% | O: -2.02% H: 0.0% C: -1.05%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -16.71% | O: -0.82% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -14.18% | O: 0.36% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -19.04% | O: -0.51% H: 1.22% C: 0.77%
CLLS | $2.47 0.4% 12K |

Health Technology

| 27.98% | O: 1.04% H: 3.08% C: 1.03%
growth study market

---

Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim
Published: 2023-08-03 (Crawled : 21:00) - prnewswire.com
BMEA | $10.87 -2.6% -2.67% 1.3M |

Professional, Scientific, and T...

| -37.04% | O: -0.11% H: 4.35% C: 1.85%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 66.3% | O: -0.53% H: 0.0% C: 0.0%
RCUS 4 | $14.59 -1.69% 0.0% 600K |

Health Technology

| -22.02% | O: 0.11% H: 1.42% C: -0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -9.29% | O: 2.43% H: 0.0% C: 0.0%
MRUS | $39.83 -1.58% -1.61% 800K |

Health Technology

| 57.76% | O: -0.23% H: 1.85% C: 0.15%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -18.71% | O: -0.8% H: 0.99% C: -1.29%
GRTX | $0.1833 -1.45% -1.47% 800K |

Health Technology

| -91.48% | O: 0.45% H: 4.02% C: 0.45%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -19.2% | O: -0.01% H: 1.23% C: -0.15%
AGEN | $5.3 6.64% 6.23% 1.5M |

Health Technology

| 242.76% | O: 0.69% H: 3.08% C: 0.0%
companies expected pancreatic tumor endocrine growth market

---

Urothelial Carcinoma Market is Expected to Showcase a Significant Growth by 2032, Assesses DelveInsight | Key Companies to Look Out - MedPacto, AstraZeneca, EMD Serono, Bayer, Merck, Bristol-Myers Squibb, Inovio, Seagen, Incyte
Published: 2023-07-31 (Crawled : 09:00) - prnewswire.com
TYRA | $14.93 1.84% 1.81% 220K |

Health Technology

| 0.7% | O: -0.42% H: 8.05% C: 3.71%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -37.1% | O: 0.34% H: 1.07% C: -1.81%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 63.75% | O: -0.44% H: 0.0% C: 0.0%
URGN | $13.78 -3.37% -3.48% 390K |

Health Technology

| -36.62% | O: -1.59% H: 0.94% C: -2.65%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -12.3% | O: 3.56% H: 0.0% C: 0.0%
NKTR | News | $1.265 -4.17% -4.35% 4.7M |

Health Technology

| 147.71% | O: -0.73% H: 4.99% C: -0.96%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -16.28% | O: -0.03% H: 1.4% C: 1.03%
ARAV | $0.0401 4.74% 4M |

Health Technology

| -96.72% | O: 6.38% H: 0.33% C: -6.67%
ADXS | $0.57 12.48% 9.5K |

Health Technology

| -51.28% | O: -1.71% H: 3.48% C: -5.43%
companies expected growth market

---

Alopecia Areata Market to Show Positive Growth at a CAGR of 26.3% During the Study Period (2019-2032), Estimates DelveInsight
Published: 2023-06-19 (Crawled : 20:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 67.69% | O: -0.41% H: 2.02% C: 1.37%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -13.4% | O: 1.71% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -16.46% | O: 0.3% H: 0.17% C: -2.63%
positive show growth study market

---

Immune Checkpoint Inhibitors Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Key Companies in the Market - Regeneron, GlaxoSmithKline, Roche, Boehringer Ingelheim, AstraZeneca, Seagen, Roche
Published: 2023-06-13 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -10.22% | O: -1.21% H: 0.0% C: -1.27%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -42.91% | O: 1.71% H: 0.0% C: -1.32%
XNCR | $18.385 -2.98% -3.07% 830K |

Health Technology

| -29.68% | O: 0.22% H: 0.69% C: 0.04%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -11.11% | O: -0.92% H: 0.32% C: -0.41%
NXTC | $1.67 6.37% 5.99% 62K |

Health Technology

| -9.58% | O: -2.99% H: 4.32% C: 1.85%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -14.94% | O: -0.48% H: 1.44% C: 0.24%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -21.51% | O: 0.18% H: 5.8% C: 5.1%
companies roche growth market

---

Antibody-drug Conjugates Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight
Published: 2023-04-10 (Crawled : 15:00) - prnewswire.com
STRO | $3.635 -3.58% -3.71% 520K |

Health Technology

| -17.21% | O: -0.87% H: 0.0% C: -5.05%
SRNE | $0.024 -8.85% 57K |

Health Technology

| -94.59% | O: -1.32% H: 1.34% C: -2.33%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -30.05% | O: -2.69% H: 1.6% C: 0.61%
IMGN | $31.23 0.03% 49M |

Health Technology

| 669.46% | O: 0.0% H: 0.99% C: -4.93%
CLLS | $2.47 0.4% 12K |

Health Technology

| 25.38% | O: 1.02% H: 0.0% C: -1.51%
growth market

---

Rheumatoid Arthritis Market is Expected to Showcase Significant Growth in the 7MM at a Minimal CAGR of 1.9% During the Study Period (2019-2032), Predicts DelveInsight
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.24% | O: 1.38% H: 0.28% C: 0.28%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 106.86% | O: 0.29% H: 0.27% C: -3.89%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -4.69% | O: 1.82% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -34.69% | O: 0.02% H: 0.36% C: -2.56%
expected growth study market

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---